Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific
- PMID: 2788705
- PMCID: PMC2189425
- DOI: 10.1084/jem.170.3.621
Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific
Abstract
The c-myc oncogene downregulates class I HLA expression in human melanoma. The major class I HLA antigens are encoded by three loci, A, B, and C, and we investigated whether these loci are suppressed equally by c-myc. In three melanoma cell lines with high c-myc expression, we analyzed mRNA, protein, and cell surface expression of the class I HLA antigens. Whereas the HLA-B locus expression was found to be strongly reduced, the HLA-A locus was expressed normally. Analysis of c-myc-transfected clones of two melanoma cell lines confirmed that c-myc preferentially suppresses the class I HLA-B locus. Immunohistochemical analysis of fresh melanoma lesions also showed that in the tumors the HLA-A loci are expressed normally, while on the majority of tumor cells no HLA-B antigen expression was found. This downregulation may have consequences for the recognition of malignant cells by tumor-infiltrating lymphocytes. Our results predict that HLA-B-restricted cytotoxic T cells will be unable to kill high c-myc-expressing melanoma cells.
Similar articles
-
c-myc down-regulates class I HLA expression in human melanomas.EMBO J. 1988 Apr;7(4):1023-9. doi: 10.1002/j.1460-2075.1988.tb02909.x. EMBO J. 1988. PMID: 3402430 Free PMC article.
-
Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.Cancer Res. 1991 Jun 15;51(12):3164-70. Cancer Res. 1991. PMID: 1904004
-
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.Clin Cancer Res. 1996 Apr;2(4):641-52. Clin Cancer Res. 1996. PMID: 9816214
-
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.Cancer Immunol Immunother. 2009 Sep;58(9):1507-15. doi: 10.1007/s00262-009-0701-z. Epub 2009 Apr 2. Cancer Immunol Immunother. 2009. PMID: 19340423 Free PMC article. Review.
-
HLA-G in melanoma: can the current controversies be solved?Semin Cancer Biol. 2003 Oct;13(5):361-9. doi: 10.1016/s1044-579x(03)00027-0. Semin Cancer Biol. 2003. PMID: 14708716 Review.
Cited by
-
Methylation-specific ligation detection reaction (msLDR): a new approach for multiplex evaluation of methylation patterns.Mol Genet Genomics. 2011 Oct;286(3-4):279-91. doi: 10.1007/s00438-011-0645-9. Epub 2011 Aug 31. Mol Genet Genomics. 2011. PMID: 21879293
-
Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors.Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11568-72. doi: 10.1073/pnas.90.24.11568. Proc Natl Acad Sci U S A. 1993. PMID: 8265591 Free PMC article.
-
Reduced stimulation of helper T cells by Ki-ras transformed cells.Immunology. 1991 Feb;72(2):277-81. Immunology. 1991. PMID: 1826672 Free PMC article.
-
An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cells.Clin Exp Immunol. 1998 Nov;114(2):173-8. doi: 10.1046/j.1365-2249.1998.00710.x. Clin Exp Immunol. 1998. PMID: 9822273 Free PMC article.
-
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.J Clin Invest. 1991 Jan;87(1):284-92. doi: 10.1172/JCI114984. J Clin Invest. 1991. PMID: 1898655 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials